TGF-β Cancer Clinical Trial Landscape Report

A Spotlight on the TGF-β Cancer Clinical Trial Landscape

The multibillion-dollar pursuit to unlock the double-edged sword of TGF-β immuno-oncology therapeutics is firmly underway. The perfect mix of continued investment, increasing evidence and the promise of preclinical and clinical success has seen this space gather momentum again after recent clinical setbacks.

The formidable TGF-β race for approval remains as dynamic and thrilling as ever; combinational therapeutics including small molecule therapies, antibodies, cell therapies and more are in preclinical and clinical development to bring novel, gold-standard, cancer immunotherapies to the market, and patients in need.

TGF-β Cancer Clinical Trial Landscape Report

The data in this infographic has been scrutinized, analyzed, and carefully selected by the Beacon Cytokine Research Team and the producers of the TGF-β for Immuno-Oncology Drug Development Summit (January 30 – February 1, 2023 San Francisco), using preclinical and clinical data from the Beacon Cytokine database, to provide you with the latest TGF-β targeting therapies cancer clinical trial data.

The data highlights recent trends, preclinical and clinically active drugs, cancer and non-cancer indications, and common trial combinations.

Download Report

You May Also Be Interested In…

Cytokine 2025 Landscape Review

Access Review

ASH 2025: Cytokine Pre-Conference Report

Access Report

Cytokine Innovation in IBD Report

View Market Report

Learn More About Cytokine

What is Beacon Cytokine?

The Most Comprehensive Way to Search the Cytokine Drug Development Landscape: Unique search ontologies based on Cytokine drug and trial characteristics
Market Leading Approach to Cytokine Preclinical & Clinical Data Curation: Manual curation of key Cytokine research and development data points by Cytokine research scientists
Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cytokine company and deal data based on their pipeline and technologies.
Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.

Learn More About Beacon Cytokine Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration